Denton C P
Centre for Rheumatology, Royal Free Hospital, London NW3 2QG, UK.
Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v54-6. doi: 10.1093/rheumatology/ken307.
Renal manifestations occur frequently in scleroderma (SSc). Commonest is a reduction in renal function due to chronic disease but most clinically important is the scleroderma renal crisis (SRC). This life-threatening complication occurs in up to 15% of the cases of dcSSc. Mortality is reduced by use of angiotensin converting enzyme (ACE) inhibitors. Renal outcome can be assessed by quantifying renal function, measuring proteinuria, exploring the frequency of renal crisis episodes and through assessment of renal outcome following SRC-such as frequency and duration of dialysis, or recovery of renal function.
肾脏表现频繁出现在硬皮病(SSc)中。最常见的是由于慢性疾病导致的肾功能减退,但临床上最重要的是硬皮病肾危象(SRC)。这种危及生命的并发症发生在高达15%的弥漫性皮肤型硬皮病(dcSSc)病例中。使用血管紧张素转换酶(ACE)抑制剂可降低死亡率。肾功能可通过量化肾功能、测量蛋白尿、探究肾危象发作频率以及评估SRC后的肾脏结局(如透析频率和持续时间或肾功能恢复情况)来进行评估。